Citation Impact 2023 Journal Impact Factor: 6.1 5-year Journal Impact Factor: 7.0 Source Normalized Impact per Paper (SNIP): 1.129 SCImago Journal Rank (SJR): 1.836 Speed 2024 Submission to first editorial decision (median days): 19 Submission to acceptance (median days): 123 ...
Citation Impact 2023 Journal Impact Factor: 6.1 5-year Journal Impact Factor: 7.0 Source Normalized Impact per Paper (SNIP): 1.129 SCImago Journal Rank (SJR): 1.836 Speed 2024 Submission to first editorial decision (median days): 19 Submission to acceptance (median days): 123 ...
Citation Impact 2023 Journal Impact Factor: 6.1 5-year Journal Impact Factor: 7.0 Source Normalized Impact per Paper (SNIP): 1.129 SCImago Journal Rank (SJR): 1.836 Speed 2023 Submission to first editorial decision (median days): 20 Submission to acceptance (median days): 121 ...
Citation Impact 2023 Journal Impact Factor: 6.1 5-year Journal Impact Factor: 7.0 Source Normalized Impact per Paper (SNIP): 1.129 SCImago Journal Rank (SJR): 1.836 Speed 2024 Submission to first editorial decision (median days): 19 Submission to acceptance (median days): 123 ...
documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) ...
The confluence of cells as a proxy of proliferation was monitored for 72 h at 2 h intervals using the IncuCyte S3 live-cell imaging system (Essen BioScience) and analyzed using IncuCyte 2019B Rev2 software. To verify the anti-proliferative (cytostatic) effect, the growth rate constants were...
Macrophages and tumour stroma cells account for the main cellular components in the tumour microenvironment (TME). Current advancements in single-cell analysis have revolutionized our understanding of macrophage diversity and macrophage–stroma interacti
Immune checkpoint inhibitors (ICIs) targeting CTLA-4 and PD-1/PD-L1 to boost tumor-specific T lymphocyte immunity have opened up new avenues for the treatment of various histological types of malignancies, with the possibility of durable responses and im
Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs ArticleOpen access26 May 2023 Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine ...
Bacterial cancer therapy was first trialled in patients at the end of the nineteenth century. More recently, tumour-targeting bacteria have been harnessed to deliver plasmid-expressed therapeutic interfering RNA to a range of solid tumours. A major limit